Orofacial Pain: Page 30

DEA to raise prescriber fee on October 1

By DrBicuspid.com staff writers

The U.S. Drug Enforcement Administration (DEA) will raise its prescriber registration fee from $731 to $888 on October 1, according to the California Dental Association.

August 2, 2020

FDA update: Naloxone and opioid labeling changes

By Tom Viola, RPh

Tom Viola, RPh, explains why dentists may want to know about naloxone and why it is being discussed currently by the U.S. Food and Drug Administration (FDA) in connection with opioid use disorder.

July 27, 2020

What to know about antibiotics and the risk of cardiovascular death

By Tom Viola, RPh

The relative safety of azithromycin was first questioned following a study published in 2012, which reported an association between azithromycin use and sudden cardiac death. Now Tom Viola, RPh, discusses why the drug is once again making headlines.

July 8, 2020

What every dentist and team member should know about these 2 drugs

By Tom Viola, RPh

A new U.S. Food and Drug Administration (FDA) warning regarding gabapentin and pregabalin recently caught the eye of Tom Viola, RPh. Now, he has some advice to share with DrBicuspid.com readers on why the warning is something they should understand and heed.

June 30, 2020

Study of cannabis effects on indigenous oral health gets $1.5M grant

By Melissa Busch

The University of Toronto has been awarded a $1.5 million grant from the Canadian Institutes of Health Research to gather the first evidence of how cannabis use affects the oral health of the country's indigenous population.

June 11, 2020

UTHSC secures $1.7M for opioid addiction studies

By DrBicuspid.com staff writers

Researchers from the University of Tennessee Health Science Center (UTHSC) have been awarded $1.7 million from the U.S. National Institutes of Health to study the genetic factors of opioid addiction.

June 7, 2020

Podcast: Thoughts on pain control and prescriptions after COVID-19's rise

By Kevin Henry

Tom Viola, RPh, has some advice to share with DrBicuspid.com readers on opioid usage and pain control as dental practices continue to move forward after the COVID-19 pandemic and subsequent disruption.

June 4, 2020

Antipain center discovered in mice may lead to new painkillers

By Melissa Busch

Scientists have discovered a small area in the brains of mice that dampens their sense of pain, which could eventually lead to new pain management treatments for humans, according to a study published on May 18 in Nature Neuroscience.

May 20, 2020

3-cm swallowed dental needle removed from patient's neck

By Melissa Busch

Clinicians removed a 3-cm needle from a patient who swallowed it, likely during a dental procedure, according to a recent case report published in the April issue of the Journal of Dental Anesthesia and Pain Medicine.

May 18, 2020

Antibiotics alter how brains of rats react to opioids

By Theresa Pablos

New research shows that antibiotics may change how the gut-brain connection works in rats dependent on opioids. The use of antibiotics altered the way the rats' brains responded to opioid use and withdrawal, according to the findings of a study published on April 27 in ENeuro.

May 7, 2020

Cannabidiol may help antibiotics fight resistant bacteria

By Melissa Busch

As many people around the U.S. celebrate the marijuana-centered holiday 4/20 today, they may not realize the plant has more to offer than a good high. Combining antibiotics with a cannabis-derived chemical may be the answer to antibiotic-resistant bacteria, according to a recent study.

April 19, 2020

Podcast: Busting one of the biggest myths about pain control and COVID-19

By Kevin Henry

Tom Viola, RPh, has some advice to share with DrBicuspid.com readers on managing pain in the age of the COVID-19 pandemic, as well as some thoughts on smoking and marijuana usage in these historic days.

March 31, 2020

Previous Page

Page 30 of 188

Next Page